NCT05238376

Brief Summary

The purpose of this project is to investigate the effects of 12 weeks of high-intensity interval training (HIIT) and resistance training on several domains of health including physical function, cognitive function, mental health, and quality of life in patients who have undergone hematopoietic stem cell transplant (HCT). In addition, the project will determine the effects of 12 weeks of HIIT and resistance training on physical function, caregiver strain, mental health, and caregiver confidence in individuals who are providing care for patients undergoing HCT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 14, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

December 2, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2025

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2025

Completed
Last Updated

September 26, 2025

Status Verified

September 1, 2025

Enrollment Period

2.2 years

First QC Date

February 2, 2022

Last Update Submit

September 25, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Adherence to prescribed exercise program, as measured by number of total sessions completed

    12 weeks

  • Compliance to prescribed HIIT sessions, as measured by total session time (in minutes)

    12 weeks

  • Compliance to prescribed HIIT sessions, as measured by number of intervals completed

    12 weeks

  • Compliance to prescribed HIIT sessions, as measured by number/percentage of intervals meeting target heart rates

    12 weeks

  • Compliance to prescribed resistance sessions, as measured by number of sets completed

    12 weeks

  • Compliance to prescribed resistance sessions, as measured by number of repetitions completed

    12 weeks

Secondary Outcomes (62)

  • Change in physical function/activity, as measured by SPPB

    Baseline, Post-intervention (week 12), 1 Year

  • Change in physical function/activity, as measured by 6-minute walk test

    Baseline, Post-intervention (week 12), 1 Year

  • Change in physical function/activity, as measured by 30-second sit-to-stand

    Baseline, Post-intervention (week 12), 1 Year

  • Change in physical function/activity, as measured by grip strength

    Baseline, Post-intervention (week 12), 1 Year

  • Change in physical function/activity, as measured by Fried Frailty

    Baseline, Post-intervention (week 12), 1 Year

  • +57 more secondary outcomes

Study Arms (2)

Patient

EXPERIMENTAL

These are patients who are 90 (±30) days post-allogeneic hematopoietic stem cell transplant. Patients will complete 12 weeks of exercise training. Patients will also complete assessments to evaluate physical function, cognitive function, mental health, social support, nutrition and diet, symptoms, quality of life, and financial status. They will use devices to capture activity data and vital signs. They will collect bio-specimens to assess microbiota and biomarkers.

Behavioral: Exercise training

Caregiver

EXPERIMENTAL

These are the assigned caregivers for the transplant patients. Caregivers will complete 12 weeks of exercise training. Caregivers will also complete assessments to evaluate physical function, caregiver support, and physical activity and exercise. They will collect bio-specimens to assess microbiota.

Behavioral: Exercise training

Interventions

12 weeks of high intensity interval training (HIIT) (3x/week) and resistance training (2x/week)

CaregiverPatient

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old
  • English speaking
  • Within 90 ± 30 days post allogenic HCT
  • ≥18 years old
  • English speaking
  • Providing post-discharge care for the patient who has undergone HCT

You may not qualify if:

  • Have an absolute contraindication to exercise including a recent acute cardiac event (\<6 months), unstable angina, uncontrolled dysthymias causing symptoms or hemodynamic compromise, symptomatic aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus, acute myocarditis or pericarditis, suspects or known dissecting aneurism, or coronary artery disease.
  • In addition to these absolute contraindications, the patient and caregiver will complete cardiopulmonary exercise testing (CPET) where the heart rate and heart rhythm will be monitored via a 12-lead ECG before, during, and after the test. The results from the CPET will be reviewed by a physician before the subject is cleared to participate in the HIIT and resistance training program. If the participant is not cleared by the physician following the CPET, then the patient and his or her caregiver will not be eligible to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke Adult Blood and Marrow Transplant Clinic

Durham, North Carolina, 27705, United States

Location

MeSH Terms

Conditions

Hematologic Neoplasms

Interventions

Exercise

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Chenyu Lin, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2022

First Posted

February 14, 2022

Study Start

December 2, 2022

Primary Completion

February 26, 2025

Study Completion

March 23, 2025

Last Updated

September 26, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations